Rearrangements of the BCL2 and BCL6 genes have been reported in a few cases of PTLD, as well as in a limited number of cases where there are gains in MYC, BCL2, and BCL6 genes [60]. This evidence concerns the gene BCL6 and post-transplant lymphoproliferative disease.